Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

This study is looking at whether daily consumption of Milk Polar Lipid-Rich Dairy Powder can help improve heart health factors in adults who have high cholesterol (dyslipidemia) and extra fat around their belly (abdominal obesity). You might be able to join if you are between 18 and 70 years old, have an LDL-C (bad cholesterol) of 130 mg/dL or higher, and meet certain waist circumference requirements. The main goal is to see how Milk Polar Lipid-Rich Dairy Powder affects your bad cholesterol levels after 8 weeks. The study status is currently unclear, and it plans to enroll 130 participants.

Study design
This is a randomized, double-blind, controlled study involving 130 participants. You would either receive a control dairy beverage or a Milk Polar Lipid-Rich Dairy Powder beverage.
What's involved
You would consume either a control dairy beverage or a Milk Polar Lipid-Rich Dairy Powder beverage for 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 8 weeks, suggesting follow-up for at least this duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05700916

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Active, Not Recruiting
EARLY_PHASE1Ages 18–70InterventionalPrevention
University of Connecticut
~130 participants
Updated 2026-08-12 on ClinicalTrials.gov
What's tested:Milk Polar Lipid-Rich Dairy PowderDairy Powder

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change from Baseline Serum LDL Cholesterol at 8 weeks
Measured over 8 weeks
Dyslipidemias
Obesity
1 sites across 1 states
Connecticut1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

LDL-C ≥ 130 mg/dL
Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
Aged 18 to 70 years

Exclusion

Renal disease
Liver disease
Diabetes
Heart disease
Stroke
Cancer
Eating disorders
Thyroid disease
Gut-associated pathologies
Autoimmune diseases
Chronic inflammatory diseases
Scleroderma
Gallbladder disease
Blood clotting disorders
Intravenous drug use
Fasting plasma/serum triglycerides \>500 mg/dL
Fasting plasma/serum glucose \>126 mg/d
Weight changes \>10% over last 4 weeks
Oral antibiotics use up to 1 month prior to and during study
Allergy or intolerance to milk products
Taking lipid-lowering medications (e.g., statins, fibrates)
Taking anti-inflammatory medications (e.g., corticosteroids)
Taking medications which primarily affect blood clotting (e.g., warfarin).
  • Change from Baseline Serum LDL Cholesterol at 8 weeks8 weeks

    Measurement of serum LDL cholesterol (mg/dL) at the beginning and end of 8-week intervention arm.